Géraldine Honnet
Chief Tech/Sci/R&D Officer at SENSORION
Network origin in Géraldine Honnet first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
22
| Public Company | Pharmaceuticals: Major | 22 |
| Holding Company | Miscellaneous Commercial Services | 10 | |
| Public Company | Biotechnology | 9 | |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France.
6
| Non-Profit Organization | Biotechnology | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Géraldine Honnet via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member | |
| University of Strasbourg | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| STALLERGENES | Pharmaceuticals: Major | Chairman Director/Board Member Sales & Marketing | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
SparingVision SAS
 SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Masters Business Admin Undergraduate Degree | |
| ELSALYS BIOTECH | Pharmaceuticals: Major | Chairman Founder | |
| University of Nice Sophia Antipolis | College/University | Doctorate Degree Doctorate Degree | |
| REDX PHARMA PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| VALNEVA | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
 Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Invus SAS (Investment Management)
 Invus SAS (Investment Management) Investment ManagersFinance Invus SAS (Investment Management) (Invus-IM) is the investment management division of Invus SAS, a private equity firm headquartered in Paris, France. The firm is owned by The Invus Group LLC in the US. Invus-IM makes equity investments in public companies. | Investment Managers | Analyst-Equity Analyst-Equity | |
| Boston College | College/University | Undergraduate Degree Masters Business Admin | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| École des Hautes Études Commerciales du Nord | College/University | Graduate Degree Undergraduate Degree | |
| ESSEC Business School | College/University | Masters Business Admin Graduate Degree | |
| BIOMÉRIEUX | Medical Specialties | Director/Board Member Sales & Marketing | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Institut de Recherches Internationales Servier
 Institut de Recherches Internationales Servier Miscellaneous Commercial ServicesCommercial Services Part of Servier SAS, Institut de Recherches Internationales Servier is a French company that provides scientific research and development services. The company is based in Suresnes, France. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Pfizer Pharmaceuticals Ltd.
 Pfizer Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Pharmaceuticals Ltd. is a pharmaceutical manufacturing company in China. It is a subsidiary compnay of Pfizer, Inc. The company was founded in 1980 and is headquartered in Beijing, CN. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | President | |
| Imperial College London | College/University | Doctorate Degree | |
| University of Oxford | College/University | Undergraduate Degree | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director of Finance/CFO | |
| Trinity College Dublin | College/University | Undergraduate Degree | |
| BAXALTA INC | Biotechnology | Corporate Officer/Principal | |
| Clinvec Solutions LLC | Miscellaneous | Corporate Officer/Principal | |
| Université Claude Bernard Lyon 1 | College/University | Doctorate Degree | |
ElevateBio LLC
 ElevateBio LLC BiotechnologyHealth Technology ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Ceregene, Inc.
 Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Erivan K. Haub School of Business | College/University | Masters Business Admin | |
PanAgora Asset Management, Inc.
 PanAgora Asset Management, Inc. Investment ManagersFinance PanAgora Asset Management, Inc. (PAM) is a SEC-registered investment advisor headquartered in Boston, Massachusetts. The firm was founded in 1989 and is a subsidiary of PanAgora Holdings, Inc., ultimately held by Power Corp. of Canada (TSE: POW) in Canada. PAM is the sponsor and investment manager for certain private unregistered investment pools, such as funds organized under US tax-qualified group trusts, domestic private funds organized as limited liability companies, and offshore private funds organized as Cayman Islands exempted companies. They also provide investment advisory services to institutional separate account clients. | Investment Managers | Analyst-Equity | |
The Invus Group LLC
 The Invus Group LLC Investment ManagersFinance The Invus Group LLC is an Independent Venture Capital firm founded in 1985 by Raymond Debbane. The Invus Group LLC is headquartered in New York, US with additional office in Paris. | Investment Managers | Private Equity Investor | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member | |
ImVax, Inc.
 ImVax, Inc. BiotechnologyHealth Technology ImVax, Inc. provides healthcare services. The company was founded in 2015 and is headquartered in Philadelphia, PA. | Biotechnology | Chief Executive Officer | |
Praxim SA
 Praxim SA Medical SpecialtiesHealth Technology Praxim SA manufactures and sells orthopedic surgical instruments. It specializes in minimal invasive products for knee arthroscopy. The company was founded by Stéphane Lavallée in 1995 and is headquartered in La Tronche, France. | Medical Specialties | Director/Board Member | |
| PIERIS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
| Sanofi-Aventis Pharmaceuticals | Corporate Officer/Principal |
Statistics
International
| France | 21 |
| United States | 20 |
| United Kingdom | 6 |
| Ireland | 3 |
| China | 3 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 14 |
| Commercial Services | 5 |
| Finance | 4 |
| Miscellaneous | 2 |
Operational
| Director/Board Member | 212 |
| Corporate Officer/Principal | 86 |
| Chairman | 64 |
| Independent Dir/Board Member | 43 |
| Chief Executive Officer | 37 |
Most connected contacts
| Insiders | |
|---|---|
| Edwin Moses | 35 |
| David Lawrence | 29 |
| Jean Bizzari | 24 |
| Stéphane Boissel | 24 |
| Richard L. Love | 23 |
| Patrick J. Langlois | 23 |
| William Parfet | 22 |
| Eric Forquenot de la Fortelle | 19 |
| Scott Myers | 18 |
| Mark Beaudouin | 18 |
| Jean-François Labbé | 18 |
| Florian Reinaud | 15 |
| Khalil Barrage | 15 |
| Cédric Moreau | 14 |
| Susan Alexander | 13 |
- Stock Market
- Insiders
- Géraldine Honnet
- Company connections